Target intelligence / Profile preview

Hemoglobin subunit gamma 1 gene promoter; Hemoglobin subunit gamma 2 gene promoter (HBG1 promoter; HBG2 promoter)

Target
HBG1 promoter; HBG2 promoter
Molecular classification
Other (regulatory DNA element), Promoter region
01

Overview

The hemoglobin subunit gamma 1 and 2 gene promoters are regulatory DNA sequences that control the expression of the HBG1 and HBG2 genes, which encode the gamma chains of fetal hemoglobin (HbF). These promoters play a crucial role in hemoglobin switching during development, being highly active in fetal liver, spleen, and bone marrow to facilitate fetal oxygen transport. In adulthood, promoter activity is usually repressed, but in certain conditions like hereditary persistence of fetal hemoglobin or beta-thalassemia, gamma-globin expression persists, partly due to promoters remaining active. Modulation of transcription factors that bind these promoters is a key therapeutic approach for hemoglobinopathies. This entry describes regulatory DNA sequences, not direct protein or receptor targets, and should be clarified or replaced with specific gene products or transcription factors if a canonical drug target is required.

Other names
gamma-globin gene promotersHBG1 upstream regulatory regionHBG2 upstream regulatory regiongamma-A and gamma-G globin gene promoters
02

Mechanism of action

Not direct ligand binding; drugs modulate transcription factor binding to these promoters, leading to increased gamma-globin (fetal hemoglobin) expression

03

Biological functions

Regulation of hemoglobin switchingControl of gamma-globin gene transcription during development
04

Disease associations

Indirectly involved in hereditary persistence of fetal hemoglobin (HPFH)sickle cell diseasebeta-thalassemiarelated hemoglobinopathies
05

Safety considerations

Risk of off-target genetic/epigenetic effects with gene editing or reactivation therapiespotential for oncogenicity with non-specific epigenetic modulators
06

Interacting drugs

Hydroxyurea and other HbF-inducing agents
07

Biomarkers

Persistent fetal hemoglobin (HbF) levelslevels of gamma-globin expression in blood

Beyond the preview

Go deeper on Hemoglobin subunit gamma 1 gene promoter; Hemoglobin subunit gamma 2 gene promoter (HBG1 promoter; HBG2 promoter).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hemoglobin subunit gamma 1 gene promoter; Hemoglobin subunit gamma 2 gene promoter (HBG1 promoter; HBG2 promoter).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call